Boston Sci Divests 2nd Non-Device Unit of BTG

Boston Sci Divests 2nd Non-Device Unit of BTG

Source: 
Medical Devices and Diagnostics Industry
snippet: 

Marlborough, MA-based Boston Sci will sell the BTG Specialty Pharmaceuticals business for $800 million in cash to Stark International Lux S.A.R.L., and SERB SAS.